AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Dutta, S Samara, E Lam, W Granneman, GR Leese, PT Padley, RJ
Citation: S. Dutta et al., Multiple-dose pharmacokinetics of atrasentan, an endothelin-A receptor antagonist, CLIN DRUG I, 21(2), 2001, pp. 129-136

Authors: Samara, E Dutta, S Cao, GL Granneman, GR Dordal, MS Padley, RJ
Citation: E. Samara et al., Single-dose pharmacokinetics of atrasentan, an endothelin-A receptor antagonist, J CLIN PHAR, 41(4), 2001, pp. 397-403

Authors: Kumar, GN Dykstra, J Roberts, EM Jayanti, VK Hickman, D Uchic, J Yao, Y Surber, B Thomas, S Granneman, GR
Citation: Gn. Kumar et al., Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction, DRUG META D, 27(8), 1999, pp. 902-908

Authors: Hsu, A Granneman, GR Bertz, RJ
Citation: A. Hsu et al., Ritonavir: clinical pharmacokinetics and interactions with other anti-HIV agents (vol 35, pg 275, 1998), CLIN PHARMA, 35(6), 1998, pp. 473-473

Authors: Ouellet, D Hsu, A Qian, J Lamm, JE Cavanaugh, JH Leonard, JM Granneman, GR
Citation: D. Ouellet et al., Effect of fluoxetine on pharmacokinetics of ritonavir, ANTIM AG CH, 42(12), 1998, pp. 3107-3112

Authors: Sham, HL Kempf, DJ Molla, A Marsh, KC Kumar, GN Chen, CM Kati, W Stewart, K Lal, R Hsu, A Betebenner, D Korneyeva, M Vasavanonda, S McDonald, E Saldivar, A Wideburg, N Chen, XQ Niu, P Park, C Jayanti, V Grabowski, B Granneman, GR Sun, E Japour, AJ Leonard, JM Plattner, JJ Norbeck, DW
Citation: Hl. Sham et al., ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease, ANTIM AG CH, 42(12), 1998, pp. 3218-3224

Authors: Wong, SL Granneman, GR
Citation: Sl. Wong et Gr. Granneman, Modeling of sertindole pharmacokinetic disposition in healthy volunteers in short term dose-escalation studies, J PHARM SCI, 87(12), 1998, pp. 1629-1631
Risultati: 1-7 |